Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · IEX Real-Time Price · USD
37.81
-0.21 (-0.55%)
Apr 18, 2024, 4:00 PM EDT - Market closed
Halozyme Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 118.37 | 234.7 | 119.22 | 148.2 | 120.68 | 58.44 | 169.24 | 67.26 | 43.79 | 61.89 | Upgrade
|
| Short-Term Investments | 217.63 | 128.6 | 622.2 | 220.31 | 301.08 | 296.59 | 300.47 | 138.22 | 65.05 | 74.23 | Upgrade
|
| Cash & Cash Equivalents | 336 | 363.29 | 741.42 | 368.51 | 421.76 | 355.03 | 469.71 | 205.48 | 108.84 | 136.12 | Upgrade
|
| Cash Growth | -7.51% | -51.00% | 101.19% | -12.63% | 18.80% | -24.42% | 128.59% | 88.79% | -20.04% | 89.05% | Upgrade
|
| Receivables | 234.21 | 231.07 | 90.98 | 97.73 | 59.44 | 30.01 | 22.13 | 15.68 | 32.41 | 9.15 | Upgrade
|
| Inventory | 127.6 | 100.12 | 53.91 | 60.75 | 29.36 | 22.63 | 5.15 | 14.62 | 9.49 | 6.41 | Upgrade
|
| Other Current Assets | 48.61 | 44.52 | 39.98 | 27.77 | 32.87 | 20.19 | 13.38 | 20.75 | 21.03 | 9.64 | Upgrade
|
| Total Current Assets | 746.42 | 739.01 | 926.29 | 554.76 | 543.44 | 427.85 | 510.37 | 256.53 | 171.77 | 161.32 | Upgrade
|
| Property, Plant & Equipment | 74.94 | 75.57 | 8.79 | 10.59 | 10.86 | 7.47 | 3.52 | 4.26 | 3.94 | 2.95 | Upgrade
|
| Goodwill and Intangibles | 889.7 | 955.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Long-Term Assets | 22.2 | 71.23 | 169.35 | 14.57 | 11.58 | 4.93 | 6.05 | 0.72 | 6.07 | 1.71 | Upgrade
|
| Total Long-Term Assets | 986.85 | 1,102 | 178.14 | 25.16 | 22.44 | 12.4 | 9.57 | 4.98 | 10.02 | 4.66 | Upgrade
|
| Total Assets | 1,733 | 1,842 | 1,104 | 579.92 | 565.87 | 440.25 | 519.95 | 261.52 | 181.79 | 165.98 | Upgrade
|
| Accounts Payable | 11.82 | 17.69 | 1.54 | 1.93 | 6.43 | 4.08 | 7.95 | 3.58 | 4.5 | 3 | Upgrade
|
| Deferred Revenue | 0 | 0 | 4.28 | 5.77 | 5.26 | 9.26 | 60.87 | 44.62 | 53.22 | 54.63 | Upgrade
|
| Current Debt | 0 | 13.33 | 89.42 | 397.23 | 19.54 | 91.51 | 77.21 | 17.39 | 21.86 | 0 | Upgrade
|
| Other Current Liabilities | 100.68 | 99.76 | 21.91 | 16.46 | 54.4 | 44.52 | -14.7 | -11 | -17.13 | -33.31 | Upgrade
|
| Total Current Liabilities | 112.49 | 130.79 | 117.15 | 421.39 | 85.64 | 149.36 | 131.33 | 54.59 | 62.46 | 24.33 | Upgrade
|
| Long-Term Debt | 1,499 | 1,493 | 787.26 | 0 | 383.05 | 34.87 | 125.14 | 199.23 | 27.97 | 49.86 | Upgrade
|
| Other Long-Term Liabilities | 37.72 | 48.16 | 3.07 | 7.49 | 5.43 | 7.13 | 55.11 | 40.18 | 48.36 | 50.43 | Upgrade
|
| Total Long-Term Liabilities | 1,537 | 1,541 | 790.33 | 7.49 | 388.47 | 42 | 180.25 | 239.41 | 76.33 | 100.29 | Upgrade
|
| Total Liabilities | 1,649 | 1,672 | 907.48 | 428.88 | 474.11 | 191.36 | 311.58 | 294 | 138.79 | 124.63 | Upgrade
|
| Total Debt | 1,499 | 1,506 | 876.67 | 397.23 | 402.59 | 126.38 | 202.35 | 216.62 | 49.83 | 49.86 | Upgrade
|
| Debt Growth | -0.45% | 71.80% | 120.70% | -1.33% | 218.55% | -37.54% | -6.59% | 334.69% | -0.05% | 0.18% | Upgrade
|
| Retained Earnings | 90.55 | 143.22 | -58.91 | -474.59 | -603.68 | -531.44 | -522.37 | -585.34 | -482.66 | -450.43 | Upgrade
|
| Comprehensive Income | -9.28 | -0.92 | -0.62 | 0.02 | 0.24 | -0.28 | -0.45 | -0.01 | -0.1 | -0.04 | Upgrade
|
| Shareholders' Equity | 83.81 | 169.8 | 196.95 | 151.05 | 91.77 | 248.89 | 208.37 | -32.48 | 43 | 41.35 | Upgrade
|
| Net Cash / Debt | -1,163.25 | -1,142.81 | -135.25 | -28.72 | 19.18 | 228.65 | 267.36 | -11.14 | 59.01 | 86.26 | Upgrade
|
| Net Cash / Debt Growth | - | - | - | - | -91.61% | -14.48% | - | - | -31.60% | 288.03% | Upgrade
|
| Net Cash Per Share | -8.67 | -8.13 | -0.92 | -0.20 | 0.13 | 1.59 | 1.92 | -0.09 | 0.47 | 0.70 | Upgrade
|
| Working Capital | 633.93 | 608.22 | 809.14 | 133.38 | 457.8 | 278.49 | 379.04 | 201.95 | 109.32 | 136.99 | Upgrade
|
| Book Value Per Share | 0.64 | 1.24 | 1.40 | 1.11 | 0.64 | 1.73 | 1.53 | -0.25 | 0.34 | 0.34 | Upgrade
|